Actualités de Lausanne

Debiopharm International SA

EMA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer

Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced that the European Medicines Agency (EMA) granted Orphan Drug Designation to Debio 1143 for treatment of Ovarian Cancer affecting around 154 ...

Debiopharm International SA

United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines

Mandaluyong, Philippines and Lausanne, Switzerland (ots/PRNewswire) - Pamorelin® one-, three- and six-month dosing option now available to patients in the Philippines United Laboratories Inc. (Unilab) and Debiopharm International SA (Debiopharm) announce the signature of an exclusive agreement for the distribution ...

Debiopharm International SA

Debiopharm International SA's Partner Yakult Honsha Co, Ltd. Announces Elplat® Approbation in Gastric Cancer in Japan

Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, is proud to congratulate its partner Yakult's commitment in obtaining approval for a supplemental new drug application for Elplat® in postoperative ...

Debiopharm International SA

Debiopharm International SA Presents Positive Preliminary Results From Phase 1 Trials in the Development of the IAP Inhibitor Debio 1143 at the 27th EORTC-NCI-AACR Symposium in Boston

Lausanne, Switzerland (ots/PRNewswire) - Recommended Dose reached and early signs of efficacy seen Debiopharm International SA (Debiopharm) - part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company - today announced significant milestones in the clinical development of the SMAC mimetic ...

Debiopharm International SA

Debiopharm International SA Acquires FibroTrap Sample Processing Technology from Spinomix

Lausanne, Switzerland (ots/PRNewswire) - - Applicable to a wide variety of sample types to isolate bacteria, viruses, tumor cells, etc. - FibroTrap improves sensitivity and shortens time taken from sample collection to results - Spinomix to focus on the development of its flagship MagPhase technology Debiopharm ...

Debiopharm International SA

Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1450 in Staphylococcal Skin Infections

Lausanne, Switzerland (ots/PRNewswire) - One year after the initiation of Phase I, Debiopharm announced the start of clinical phase II for Debio 1450 in ABSSSI and presentation of new data at ECCMID Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical ...

Debiopharm International SA

Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference

Lausanne, Switzerland (ots/PRNewswire) - Debiopharm presents preclinical results for 2 anti-cancer targeted therapies Debio 1143 and Debio 1347 Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet ...

Galderma

World's Leading Rosacea Experts Join Forces for First Global Rosacea Awareness Month to Help Drive Awareness and Extend Support for the 40 Million People Affected by Rosacea

Lausanne, Switzerland (ots/PRNewswire) - For non-US media - Global Rosacea Tweetathon set to bring the realities of living with rosacea under the spotlight #ChatRosacea Today the world's first Global Rosacea Coalition, supported by the National Rosacea Society and many leading rosacea experts, called for greater ...

Ecole hôtelière de Lausanne

Ecole hôtelière de Lausanne: Holding company created to support its development ambitions as the world number 1 in hospitality management education

Lausanne, Switzerland (ots) - Ecole hôtelière de Lausanne (EHL) deploys its strategic development objectives under the leadership of its Board of Governors. The newly formed "EHL SA" holding company aims to ensure the management of its various specialized business units. This holding company structure rationalizes ...

Debiopharm International SA

Debiopharm Diagnostics Leads Investment Round in GenePOC With Emerillon Capital

Lausanne, Switzerland (ots/PRNewswire) - GenePOC is a Canadian company which has developed a rapid, innovative, low cost MDx platform for the detection of infectious diseases Debiopharm Diagnostics [https://www.debiopharm.com/about-us/debiopharm-diagnostics-s-a.html ], part of Debiopharm Group [https://www.debiopharm.com/about-us/debiopharm-group.html ](TM), is proud ...

Debiopharm International SA

Debiopharm Group(TM) Regains Full Rights to Alisporivir Program

Lausanne, Switzerland (ots/PRNewswire) - - Novartis returns Alisporivir (DEB025) to Debiopharm Group(TM) including all rights for HCV and other indications - Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company, today announced that it has updated its arrangement with Novartis to regain full rights to Alisporivir (DEB025) currently completing two Phase 2 studies of interferon-free treatment in ...

Debiopharm International SA

FDA Grants Fast Track Designation to Debiopharm Group's Antibiotic Debio 1450

Lausanne, Switzerland (ots/PRNewswire) - - Debio 1450, oral/IV FabI inhibitor active against all Staphylococcus species has received Fast Track designation for ABSSSI (acute bacterial skin and skin structure infections) - Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) ...

Ecole hôtelière de Lausanne

New Master of Science HES-SO in Global Hospitality Business

Lausanne (ots) - Ecole hôtelière de Lausanne (EHL), the Conrad N. Hilton College at the University of Houston and the School of Hotel and Tourism Management (SHTM) at The Hong Kong Polytechnic University (PolyU) join forces to offer an exceptional new Master's program in Global Hospitality Business. Representatives from the three leading universities in hospitality management and industry partners join a conference ...

IMD

IMD releases new World Talent Ranking

Lausanne (ots) - IMD, a top-ranked global business school, just released its first annual World Talent Report. The report introduces the IMD World Talent Ranking based on the long-established IMD World Competitiveness Yearbook. It assesses a country's ability to develop, attract and retain talent for companies based on three factors: 1] Investment and ...

Galderma

SKINPACT Programme Launched Today with New Global Awards Initiative to Support the Dermatology Community

Lausanne, Switzerland (ots/PRNewswire) - - Galderma, in partnership with the International League of Dermatological Societies, has launched the search for initiatives that will fulfil an important role in strengthening the global dermatology community - The SKINPACT Awards, part of a wider programme with social ...

IMD

Finance for Executives: A Practical Guide for Managers / A new book from IMD business school professor Nuno Fernandes

Lausanne, Switzerland (ots) - Ambitious executives know that understanding finance is increasingly key to their chances of landing that coveted job-whether it's head of a division, country manager, a broader regional role or other posts on the way to the C- suite. The good news is that finance does not need to be ...

African Press Organization - APO

APO (African Press Organization) Opens Office in Dubai / The sole press release wire in Africa, and the global leader in media relations related to Africa

Lausanne (ots) - APO (African Press Organization) (http://www.apo-opa.com), the sole press release wire in Africa, and the global leader in media relations related to Africa, announced today the opening of an office in Dubai (United Arab Emirates) to serve the Middle East, where demand for APO media relations ...

Association Mercy Ships

2

Roland Decorvet, Chairman & CEO of Nestlé China, to join the organization Mercy Ships as Managing Director of its hospital ship Africa Mercy (PICTURE)

Galderma

Mirvaso® (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission

Lausanne, Switzerland (ots/PRNewswire) - - Galderma portfolio expands to offer a fast onset and long-acting alpha-2 adrenergic receptor agonist - Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today announced that the European Commission has granted Marketing Authorisation in ...

IMD

IMD launches "QUEST: LEADING GLOBAL TRANSFORMATIONS" / The IMD Guide to the Seven Journeys Reshaping Corporations Today

Lausanne, Switzerland (ots) - IMD, a top-ranked global business school based in Switzerland, today published a new book that aims to help business leaders and their organizations navigate major transformations more effectively. Titled "Quest: Leading Global Transformations ...

Debiotech S.A.

Debiotech will be introducing its new insulin JewelPUMP2 for Diabetes Type 2 during the 2014 ATTD conference in Vienna, Austria

Lausanne, Switzerland (ots) - - Click here for Picture 1 (http://www.debiotech.com/news/images/nw181_1.png ) The JewelPUMP2, which will be unveiled for the first time at the ATTD 2014 congress on February 5th in Vienna, is a new product dedicated to the Diabetes Type 2 market, based on Debiotech's innovative ...

IMD

IMD appoints professor Arturo Bris to head the World Competitiveness Center / Center plans to develop new research and benchmarking services

Lausanne (ots) - IMD (http://www.imd.org/ ), a top-ranked global business school based in Switzerland, today announced the appointment of Arturo Bris (http://www.imd.org/about/facultystaff/bris.cfm ) as the new director of the IMD World Competitiveness Center (http://www.imd.org/wcc/ ) (WCC). Professor Bris, who is ...

Biocartis

Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test

Lausanne, Switzerland And Mechelen, Belgium (ots/PRNewswire) - Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability (MSI) biomarkers for several cancers, in particular colorectal cancer (CRC). This agreement will enable Biocartis to develop a unique and user-friendly assay, whereby MSI biomarkers can simply ...

Biocartis

Biocartis Poised for 2014 Commerical Launch with EUR 30 Million Series E Equity Fundraising

Mechelen, Belgium And Lausanne, Switzerland (ots/PRNewswire) - Biocartis, a molecular diagnostics company developing and commercializing innovative, easy to use platforms and clinically relevant assays, announced today the completion of an EUR 30 million Series E equity fundraising. The additional capital will be ...